5 Einträge gefunden

1. Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

   1. Hehlmann, Rüdiger
   2. Voskanyan, Astghik
   3. Lauseker, Michael
   4. Pfirrmann, Markus
   5. Kalmanti, Lida
   6. Rinaldetti, Sebastien
   7. Kohlbrenner, Katharina

   2020 - Forschungsinformationssystem des UKE
2. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

   1. Hehlmann, Rüdiger
   2. Voskanyan, Astghik
   3. Lauseker, Michael
   4. Pfirrmann, Markus
   5. Kalmanti, Lida
   6. Rinaldetti, Sebastien
   7. Kohlbrenner, Katharina

   2020 - Forschungsinformationssystem des UKE
3. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

   1. Kalmanti, Lida
   2. Saussele, Susanne
   3. Lauseker, Michael
   4. Proetel, Ulrike
   5. Müller, Martin C
   6. Hanfstein, Benjamin
   7. Schreiber, Annette

   2014 - Forschungsinformationssystem des UKE
4. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV

   1. Hehlmann, Rüdiger
   2. Müller, Martin C
   3. Lauseker, Michael
   4. Hanfstein, Benjamin
   5. Fabarius, Alice
   6. Schreiber, Annette
   7. Proetel, Ulrike

   2014 - Forschungsinformationssystem des UKE
5. Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia

   1. Pfirrmann, Markus
   2. Saussele, Susanne
   3. Hochhaus, Andreas
   4. Reiter, Andreas
   5. Berger, Ute
   6. Hossfeld, Dieter K
   7. Nerl, Christoph

   2014 - Forschungsinformationssystem des UKE